In January 2021, Combined Therapeutics began working with the Precisions Vaccine Program (PVP) at Boston Children’s Hospital – Harvard Medical School to evaluate our mRNA-based molecular adjuvants in their preclinical vaccine models.
Partner with Us
If you are interested in partnering with Combined Therapeutics, complete and submit the form below.
